ArticleFrontiers in oncology2026

Outcome of elective cemiplimab discontinuation in locally advanced or metastatic cutaneous squamous cell carcinoma patients achieving a complete remission.

Tina Fung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.